BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Genetown

  Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentation at the Goldman, Sachs & Co. 29th Annual Global Healthcare Conference

  June 9, 2008

   · 

  1 min read
• Bio NC

  Laboratory Corporation of America Holdings is Scheduled to Present at the Goldman, Sachs & Co. Twenty-Ninth Annual Global Healthcare Conference

  June 9, 2008

   · 

  1 min read
• Biotech Beach

  National Geographic Channel’s Documentary, Explorer: Science of Cats, Features Illumina, Inc.'s(R) VeraCode® Technology

  June 9, 2008

   · 

  1 min read
• Drug Development

  Hollis-Eden Pharmaceuticals Inc. Reports Additional Positive Data from Phase I/II Clinical Trial with TRIOLEX(TM) Supporting Anti-Inflammatory Approach to Treating Type 2 Diabetes

  June 9, 2008

   · 

  1 min read
• Business

  Astex Therapeutics Announces New Drug Discovery Alliance with Janssen Pharmaceutica N.V.

  June 9, 2008

   · 

  2 min read
• Pharm Country

  Celgene Corporation to Present at Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference

  June 9, 2008

   · 

  1 min read
• Business

  Dr. Alex Giaquinto Joins Biothera Board of Directors

  June 9, 2008

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. Release: A New Analysis Released at American Diabetes Association: Lower Risk of Symptomatic Hypoglycemia with JANUVIA(TM) (sitagliptin) Compared to Glipizide on a Background of Metformin in Patients with Type 2 Diabetes

  June 9, 2008

   · 

  1 min read
• Biotech Bay

  DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes

  June 9, 2008

   · 

  4 min read
• Drug Development

  Raptor Pharmaceutical Inc. Receives FDA Orphan Drug Designation for Cysteamine in Huntington’s Disease Potential Efficacy in Huntington’s Disease Already Demonstrated

  June 9, 2008

   · 

  7 min read